Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

Clinical trial NCT05330364 · UNKNOWN

Trial details

NCT number: NCT05330364
Sponsor: Ge Zheng
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2021-06-01
Primary completion: 2023-06-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.